Skip to content
10-Q

Quarterly Report

Turn Therapeutics Inc. TTRX

0001213900-25-109586

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 29.45M sh
Shares Diluted Q3 2025 · Sep 30, 2025 27.98M sh
Shares Diluted Q3 2025 · Sep 30, 2025 27.48M sh
Shares Diluted Q3 2025 · Sep 30, 2024 26.65M sh
Shares Diluted Q3 2025 · Sep 30, 2024 26.55M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$1.39M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$930.76K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $513.7K
Cash And Equivalents Q3 2025 · Sep 30, 2024 $498.29K
Stockholders Equity Q3 2025 · Sep 30, 2025 $504.02K
Stockholders Equity Q3 2025 · Dec 31, 2024 −$177.43K
Stockholders Equity Q3 2025 · Sep 30, 2024 −$414.3K
Stockholders Equity Q3 2025 · Dec 31, 2023 $85.77K
Current Liabilities Q3 2025 · Sep 30, 2025 $2.31M
Current Liabilities Q3 2025 · Dec 31, 2024 $707.93K
Total Liabilities Q3 2025 · Sep 30, 2025 $3.79M
Total Liabilities Q3 2025 · Dec 31, 2024 $2.23M
Current Assets Q3 2025 · Sep 30, 2025 $3.29M
Current Assets Q3 2025 · Dec 31, 2024 $1.1M
Total Assets Q3 2025 · Sep 30, 2025 $4.3M
Total Assets Q3 2025 · Dec 31, 2024 $2.05M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.07
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.03
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.05
Eps Basic Q3 2025 · Sep 30, 2025 −$0.07
Eps Basic Q3 2025 · Sep 30, 2025 −$0.13
Eps Basic Q3 2025 · Sep 30, 2024 −$0.03
Eps Basic Q3 2025 · Sep 30, 2024 −$0.05
Sga Expense Q3 2025 · Sep 30, 2025 $1.75M
Sga Expense Q3 2025 · Sep 30, 2025 $3.43M
Sga Expense Q3 2025 · Sep 30, 2024 $519.71K
Sga Expense Q3 2025 · Sep 30, 2024 $1.23M
Rd Expense Q3 2025 · Sep 30, 2025 $158.7K
Rd Expense Q3 2025 · Sep 30, 2025 $230.64K
Rd Expense Q3 2025 · Sep 30, 2024 $153.28K
Rd Expense Q3 2025 · Sep 30, 2024 $236.19K
Net Income Q3 2025 · Sep 30, 2025 −$1.9M
Net Income Q3 2025 · Sep 30, 2025 −$3.47M
Net Income Q3 2025 · Sep 30, 2024 −$666.44K
Net Income Q3 2025 · Sep 30, 2024 −$1.45M
Operating Income Q3 2025 · Sep 30, 2025 −$1.91M
Operating Income Q3 2025 · Sep 30, 2025 −$3.67M
Operating Income Q3 2025 · Sep 30, 2024 −$672.99K
Operating Income Q3 2025 · Sep 30, 2024 −$1.47M